FDA Inspection
Baxalta US Inc.Baxalta US Inc. – FDA Inspection, Sep 18, 2025
Record Details
This FDA Inspection record concerns Baxalta US Inc., with an inspection on September 18, 2025, issued by the Los Angeles District Office, covering biologics.
View Company Profile
ID · 95291689-7d92-4668-a518-7c2443655647
Inspection Facts
- Inspection number
- 1279237
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.188(b)(2)Identification of Equipment and Lines
- 21 CFR 803.50(a)(2)Individual Report of Malfunction
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Baxalta US Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 7, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 17, 2020 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 19, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 10, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 28, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Baxalta US Inc.
- FDA Inspection 1166545 - 2022-04-07
- FDA Inspection 1118072 - 2020-01-17
- FDA Inspection 1038757 - 2018-01-19
- FDA Inspection 972505 - 2016-03-10
- FDA Inspection 870344 - 2014-02-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.